LillyDirect UK: What It Is, How It Works, and What It Means for Patients

Medical information reviewed by Dr Saira Bano, GP and Medical Director, SwiftDoctor. Last reviewed: September 2026.

---

Summary

LillyDirect is Eli Lilly's direct-to-patient service. It launched in the United States in early 2024 and arrived in the UK in late June 2026. The two versions share a name but work very differently, because UK law does not allow a manufacturer to sell prescription-only medicines straight to the public.

In the UK, LillyDirect is a dispensing and delivery service only. It does not assess you, prescribe for you, or make any clinical decisions. A UK-regulated healthcare provider still has to consult with you and issue a private prescription first. LillyDirect then arranges for that prescription to be dispensed and delivered by one of its partner pharmacies.

	LillyDirect (US)	LillyDirect (UK)
Launched	January 2024	June 2026
Clinical assessment	Via third-party telehealth providers linked from the platform	None – your own regulated provider assesses and prescribes
Who dispenses	Lilly-contracted pharmacies	Pharmacy2U and Onescript (Blueco Healthcare)
Medicines at launch	Zepbound, Mounjaro, insulins and others	Mounjaro (tirzepatide) only
Direct patient sign-up	Yes	No – access is via a registered private provider
NHS involvement	N/A	None – private prescriptions only

The short version: LillyDirect UK is a supply-chain route, not a clinic. Whether you are a good candidate for Mounjaro, what dose you should be on, and how you are monitored still depend entirely on the prescriber you choose.

---

What is LillyDirect and how does it work?

Eli Lilly is the manufacturer of Mounjaro (tirzepatide), the GIP/GLP-1 injection licensed in the UK for both type 2 diabetes and chronic weight management. LillyDirect is Lilly's attempt to get its own medicines to patients through a channel it controls, rather than relying entirely on the traditional wholesaler-to-pharmacy chain.

The US model

In the United States, LillyDirect is a patient-facing website. People can sign up, be connected to an independent telehealth provider for an assessment, receive a prescription, and have it filled by a Lilly-contracted pharmacy. Lilly also sells self-pay vials of some products at a discount through the platform. The US regulatory environment permits this kind of manufacturer-to-consumer arrangement.

The UK model

UK medicines law is stricter. A pharmaceutical company cannot advertise prescription-only medicines to the public, nor sell them directly. So the UK version of LillyDirect has been built as a post-prescription service:

1. A private healthcare provider (a CQC-registered online clinic or pharmacy prescribing service, for example) registers with LillyDirect.
2. That provider carries out its usual consultation and, if appropriate, issues an electronic private prescription for Mounjaro.
3. The prescription is routed to a LillyDirect dispensing partner – currently Pharmacy2U or Onescript – which dispenses it and delivers it to the patient's home in discreet, temperature-appropriate packaging with real-time tracking.

Lilly has been explicit that it plays no clinical role. The prescriber keeps full responsibility for the decision to treat, the dose, and ongoing care. Lilly's stated aim is to guarantee that what arrives at the patient's door is authentic, correctly stored Lilly product, and to squeeze counterfeit tirzepatide out of the supply chain.

---

Which medicines does LillyDirect UK cover?

At launch, Mounjaro (tirzepatide) is the only medicine available through LillyDirect UK. Lilly has said it will evaluate adding further products over time. Likely candidates include:

• Foundayo (orforglipron) – Lilly's once-daily oral GLP-1 tablet, which is already available privately in the UK from regulated providers such as SwiftDoctor.
• Trulicity (dulaglutide) – a weekly GLP-1 injection licensed for type 2 diabetes only, not weight management.
• Lilly insulin products.

Mounjaro vs Zepbound

One point that causes real confusion: in the US, tirzepatide is sold under two brand names – Mounjaro for type 2 diabetes and Zepbound for weight management and sleep apnoea. In the UK, Mounjaro is the single licensed brand for both indications. Zepbound is not licensed by the MHRA and should not be bought from overseas sellers or imported. Anything sold in the UK as "Zepbound" is at best grey-market and at worst counterfeit.

What tirzepatide is licensed for in the UK

• Type 2 diabetes – as an adjunct to diet and exercise, alone or with other glucose-lowering medicines.
• Weight management – in adults with a BMI of 30 kg/m² or over, or 27 kg/m² or over with at least one weight-related condition (for example high blood pressure, high cholesterol, sleep apnoea or prediabetes), alongside a reduced-calorie diet and increased physical activity.

A prescriber should confirm you meet the licensed criteria before starting treatment. If a service is willing to prescribe without checking your BMI, medical history and current medicines, that is a warning sign, whoever ends up dispensing the medicine.

Side effects and risks to be aware of

Tirzepatide is generally well tolerated, but it is not a trivial medicine. The most common effects are gastrointestinal – nausea, vomiting, diarrhoea, constipation and reduced appetite – and they are usually worst in the first few weeks and after each dose increase. Less common but more serious risks include:

• Pancreatitis – severe, persistent abdominal pain that may spread to the back needs urgent assessment.
• Gallbladder problems – gallstones and cholecystitis are more common with rapid weight loss.
• Dehydration and acute kidney injury – usually secondary to prolonged vomiting or diarrhoea.
• Hypoglycaemia – mainly a risk when tirzepatide is combined with insulin or a sulfonylurea.
• Diabetic retinopathy complications – rapid improvement in blood glucose can temporarily worsen existing eye disease in people with diabetes.
• Reduced absorption of oral medicines – including the combined oral contraceptive pill. Additional contraception is advised for four weeks after starting and after each dose increase.

Tirzepatide is not recommended in pregnancy or breastfeeding, and should be stopped at least one month before trying to conceive.

Any side effect can be reported to the MHRA through the Yellow Card scheme.

---

Safety, regulation and what to check before you order

LillyDirect solves one problem well – authenticity of supply. It does not, on its own, tell you anything about the quality of the clinical service prescribing the medicine. That still rests with the provider you choose, so it is worth understanding who regulates what.

Regulator	What it covers
MHRA (Medicines and Healthcare products Regulatory Agency)	Licenses medicines and monitors their safety once on the market
GPhC (General Pharmaceutical Council)	Registers pharmacists and pharmacies, including online pharmacies, and pharmacist independent prescribers
GMC (General Medical Council)	Registers doctors and sets standards for prescribing, including remote prescribing
CQC (Care Quality Commission)	Inspects and regulates independent healthcare providers in England, including online clinics

A simple checklist for any online provider

• Is the pharmacy GPhC-registered? Look for the registration number on the website and check it on the GPhC register. SwiftDoctor's GPhC registration number is 9012809.
• Is the prescriber registered? GMC for doctors, GPhC for pharmacist prescribers, NMC for nurse prescribers. Their name and number should be easy to find.
• Is the clinic CQC-registered? In England, an online clinic providing consultations and prescribing should be registered with the CQC and its inspection reports should be public.
• Does the consultation actually assess you? A proper service will ask about your weight and height, medical history, current medicines, and anything that would make tirzepatide unsuitable. Baseline checks such as blood pressure, HbA1c and kidney function are good practice, particularly in people with diabetes.
• Is there ongoing support? Dose escalation, side-effect management and regular weight reviews are part of the treatment, not optional extras.
• Will they tell your GP? With your consent, your provider should share a record of the treatment with your GP so your NHS records are complete.

The main concern regulators have raised about online weight-loss prescribing is fragmented care – people receiving injections without anyone taking an overall view of their health. Choosing a provider that combines prescribing, pharmacy and follow-up in one place reduces that risk.

---

Is LillyDirect available in the UK?

Yes. LillyDirect UK went live on 25 June 2026 with Mounjaro as the only product, dispensed by Pharmacy2U and Onescript. It is a private service: there is no NHS pathway through LillyDirect, and you cannot sign up to it directly as a patient. You access it only if your private provider has chosen to route its prescriptions through it.

Other ways to access Mounjaro in the UK

• NHS, type 2 diabetes – recommended by NICE (TA924) for eligible patients as part of diabetes management.
• NHS, weight management – NICE recommends tirzepatide (TA1026) for adults meeting specific BMI and comorbidity thresholds. Rollout is phased over several years and access remains limited in most areas.
• Regulated private providers – CQC-registered clinics and GPhC-registered pharmacies, such as SwiftDoctor, can assess you and, if appropriate, prescribe and dispense Mounjaro privately.

How SwiftDoctor fits in

SwiftDoctor is an independent, UK-based online pharmacy and clinic, and we are partnering with LillyDirect for the dispensing and delivery of Mounjaro. That is the only part of our service that LillyDirect touches. Our clinicians – led by Dr Saira Bano (GP and Medical Director) and Nasir Ali (Superintendent Pharmacist and independent prescriber) – still assess every patient before any prescription is issued, make every prescribing decision, and provide all follow-up as your dose changes. Eli Lilly funds the LillyDirect dispensing and delivery service and has no role in your clinical care.

Using LillyDirect is optional. You can opt out at any time without it affecting your access to treatment, in which case your Mounjaro is dispensed and delivered by our own GPhC-registered pharmacy in Wakefield instead. Full details are on our LillyDirect and your Mounjaro treatment page.

If you would like to find out whether Mounjaro or Foundayo is suitable for you, you can start an online consultation with our clinical team.

---

Frequently asked questions

Can I order from LillyDirect UK without a prescription?
No. Mounjaro is a prescription-only medicine. LillyDirect UK only dispenses prescriptions issued by a registered private healthcare provider. There is no consultation, assessment or prescribing on the LillyDirect platform itself.

Is Zepbound available in the UK?
No. Zepbound is a US brand name for tirzepatide and is not licensed by the MHRA. In the UK, tirzepatide is sold only as Mounjaro, which covers both type 2 diabetes and weight management. Products advertised as Zepbound to UK customers should be avoided.

How is LillyDirect UK different from the US version?
The US service lets patients sign up directly, connects them to telehealth prescribers and sells some products at self-pay prices. The UK service is dispensing and delivery only: a UK-regulated provider must consult with you and prescribe first, and Lilly has no role in the clinical decision.

Is Mounjaro from LillyDirect cheaper?
LillyDirect UK has not published patient pricing. What you pay is set by your private provider, who buys the medicine and charges for the consultation and dispensing. It is worth comparing the total cost of treatment, including follow-up, rather than the headline price of a single pen.

Does using LillyDirect mean the medicine is safer?
It means the product is guaranteed genuine and has been stored correctly, which matters given the counterfeit tirzepatide found in circulation. It does not change the medicine's side effects or the importance of being properly assessed and monitored. Whether your Mounjaro comes through LillyDirect or a GPhC-registered pharmacy sourcing through licensed UK wholesalers, such as SwiftDoctor’s own pharmacy, it is the same authentic medicine.

Should I tell my GP I'm taking Mounjaro privately?
Yes. Tirzepatide can interact with other medicines and affects blood glucose, so your GP should know. A good private provider will offer to send a summary to your GP with your consent.

---

SwiftDoctor is an independent online pharmacy and clinic regulated by the GPhC (registration 9012809) and the CQC. SwiftDoctor uses LillyDirect for the dispensing and delivery of Mounjaro only; all clinical decisions are made by SwiftDoctor’s own clinicians and patients may opt out of LillyDirect at any time. Other brand names are used for identification only. This article is for general information and is not a substitute for individual medical advice. Always speak to a qualified healthcare professional before starting, stopping or changing any medicine.